Year-over-year net earnings per share growth for the last 12 months: Trevi Corp (TRVI)

Brandmark of Trevi Therapeutics, Inc. (TRVI)

The development of drugs for itching and coughing by Trevi Therapeutics (TRVI) is independent of market cycles, relying instead on the pace of clinical trials. The humanitarian profile of neuromedicine minimizes geopolitical risks due to the localization of supply chains in Western countries. Financial stability is based on targeted funding and patent protection of future cash flows. The current quarterly EPS trend clearly demonstrates profit dynamics, where the -65.40 level captures the current state.

TRVI: trevitherapeutics.com Year-over-year earnings per share growth rate for the last twelve months 07/04/2022 - 11/17/2026

Analytical breakdowns for Trevi Therapeutics

- share price and expert price forecast:
Summary company analytics:Trevi Therapeutics Inc - TRVI
Flagship merchandise of Trevi Therapeutics

Trevi Therapeutics (TRVI) operates under an R&D model where fixed costs for developing cough medications define its financial profile. This quarterly EPS chart visualizes the net income per share trend. This metric measures earnings growth rates, reflecting the contraction or expansion of operating margins. For Trevi Therapeutics (TRVI), an increase in this indicator would signal a transition from the cost-intensive phase to excess profits driven by IP. Trend analysis allows investors to avoid purchasing the asset during a phase of fading momentum.

Competitor analysis

BIIB: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Neurocrine Biosciences Inc (NBIX)|RGC (Regencell Bioscience Ltd) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Axsome Therapeutics, Inc. AXSM|Year-over-year net earnings per share growth for the last 12 months ACAD (ACADIA Pharmaceuticals Inc.)|XENE: Year-over-year net earnings per share trend for the last twelve months|Viking Therapeutics, Inc. - Year-over-year net earnings per share growth for the last 12 months|Year-over-year net earnings per share change for the last twelve months Supernus Pharmaceuticals (SUPN)|CPRX: Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months DNLI (Denali Therapeutics)|HRMY: Quarterly EPS earnings growth|BHVN (Biohaven Pharmaceutical) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last twelve months Amylyx|Year-over-year net earnings per share growth for the last 12 months Praxis Medicines (PRAX)|Year-over-year net earnings per share growth for the last 12 months AVXL (Anavex Life Sciences)|Year-over-year net earnings per share growth for the last 12 months CeriBell CBLL|Year-over-year earnings per share growth for the last twelve months Prothena Biosciences PRTA|Quarterly EPS earnings growth Alector, Inc. ALEC|ANNX - Year-over-year earnings per share growth for the last twelve months|OMER - Quarterly EPS earnings growth|Neurogene (NGNE) - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months AC Immune SA (ACIU)|Year-over-year net earnings per share growth for the last 12 months VYGR|Quarterly EPS earnings growth Neumora Therapeutics Inc|Year-over-year earnings per share growth for the last twelve months scilexholding.com (SCLX)|Year-over-year net earnings per share change for the last twelve months Tevogen Bio Inc.|Year-over-year earnings per share growth for the last twelve months Alpha Cognition Inc. ACOG|Quarterly EPS earnings growth Cognition Therapeutics CGTX|IKT: Year-over-year net earnings per share growth for the last 12 months|SAVA (Cassava Sciences) - Year-over-year earnings per share growth for the last 12 months|Assertio Holdings, Inc. (ASRT) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last 12 months COYA|Year-over-year earnings per share growth for the last twelve months Vistagen|Year-over-year net earnings per share growth for the last 12 months Ovid Therapeutics (OVID)|Year-over-year earnings per share growth for the last twelve months Acumen Pharmaceuticals Inc. (ABOS)|CRVO - Earnings per share growth in annualized terms for the last twelve months|Alterity Therapeutics Limited - Year-over-year net earnings per share growth for the last 12 months|CLNN: Year-over-year earnings per share growth for the last 12 months|pepgen.com - Quarterly EPS earnings growth|JUNS (Jupiter Neurosciences) - Year-over-year earnings per share growth for the last 12 months|Relmada (RLMD) - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months Annovis Bio (ANVS)|GRCE (gracetx.com) - Quarterly EPS earnings growth|Firefly Neuroscience Inc (AIFF) - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months KLTO (Klotho Neurosciences Inc)|NeuroSense Therapeutics Ltd - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth RVPH (Reviva Pharmaceuticals, Inc.)|Year-over-year earnings per one share growth for the last 12 months MTVA|NeurAxis Inc - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months Helius Medical Technologies, Inc. HSDT|PASG: Quarterly EPS earnings growth|Neuphoria (NEUP) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months Minerva Neurosciences Inc|Athira Pharma Inc (ATHA) - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months ADXN (Addex Therapeutics)|Quarterly EPS earnings growth Alzamend Neuro Inc. (ALZN)|Cyclerion Therapeutics, Inc. - Year-over-year net earnings per share growth for the last 12 months|PTIX (Protagenic Therapeutics) - Year-over-year net earnings per share trend for the last twelve months|Pasithea Therapeutics Corp - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months Cortigent CRGT|ATXI (Avenue Therapeutics, Inc) - Year-over-year net earnings per share growth for the last 12 months|Brainstorm Cell Therapeutics, Inc. - Year-over-year earnings per one share growth for the last 12 months|Year-over-year net earnings per share growth for the last 12 months CARA|Earnings per share growth in annualized terms for the last twelve months chromocell.com CHRO|Year-over-year earnings per share growth for the last twelve months Eliem Therapeutics, Inc. (ELYM)|ITCI (Intra-Cellular Therapies, Inc.) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth LBPH (Longboard Pharmaceuticals Inc)|Quarterly EPS earnings growth Marinus Pharma MRNS|nkgenbiotech.com - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months NeuroBo Pharmaceuticals, Inc.|Sage Therapeutics (SAGE) - Year-over-year earnings per share growth for the last twelve months|SNPX - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Trevena, Inc|Vigil Neuroscience (VIGL) - Year-over-year net earnings per share change for the last twelve months|Quarterly EPS earnings growth WENA|Quarterly EPS earnings growth cerevel.com (CERE)